AstraZeneca is making flu safety extra handy with the launch of an at-home supply choice for FluMist, its nasal spray flu vaccine, the corporate introduced Friday.
In the marketplace since 2003, FluMist was beforehand solely out there at pharmacies or medical doctors’ workplaces.
Starting Friday, eligible prospects can order it on-line and have it shipped on to their door, permitting dad and mom to vaccinate their kids at residence with out pictures or a visit to the pharmacy.
The spray could be self-administered by adults as much as age 49, whereas caregivers can provide it to kids ages 2–17, the corporate stated.
The FDA approved FluMist for self- and caregiver-administration in September 2024, after analysis confirmed adults over 18 may safely and successfully administer it to eligible people.
AstraZeneca hopes the needle-free choice and at-home comfort will enhance vaccination charges this 12 months.
Final 12 months’s flu season noticed the very best variety of flu-related deaths for youngsters for a non-pandemic 12 months — 267 — because the 2009 H1N1 pandemic, in line with the Centers for Disease Control and Prevention. Well being specialists stress that vaccination stays one of the best safety towards the virus, although getting children vaccinated could be a problem.
The CDC continues to suggest that everybody 6 months and older get a flu vaccine this fall.
Most medical health insurance plans are anticipated to cowl the fee, with a transport payment for 4 FluMist doses estimated at underneath $10.
The corporate added for individuals who qualify, the nasal spray gives security and effectiveness similar to conventional flu pictures.
